Radiopharm Theranostics Limited Financial Overview
Radiopharm Theranostics Limited's market cap is currently AU$66.74M. The company's EPS TTM is AU$-0.01; its P/E ratio is -1.35; Radiopharm Theranostics Limited is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
